Cleared Traditional

K221539 - GammaTile (FDA 510(k) Clearance)

Nov 2022
Decision
166d
Days
Class 2
Risk

K221539 is an FDA 510(k) clearance for the GammaTile. This device is classified as a Source, Brachytherapy, Radionuclide (Class II - Special Controls, product code KXK).

Submitted by Gt Medical Technologies (Tempe, US). The FDA issued a Cleared decision on November 9, 2022, 166 days after receiving the submission on May 27, 2022.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.5730.

Submission Details

510(k) Number K221539 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 27, 2022
Decision Date November 09, 2022
Days to Decision 166 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code KXK - Source, Brachytherapy, Radionuclide
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.5730